Biomedical and pharmaceutical properties of pectinThis paper is an overview on the Pectins which are a group of polysaccharides from plant cells. Structural diversity makes functionality of the pectins versatile with a variety of biological, technofunctional, biomedical, and pharmaceutical properties. Nearly all the plants contain pectin, however, the majority of it is used commercially and is derived from citrus fruits, specifically oranges, lemons, grapefruit, and apples. Commercial production is judged on new features and applications in addition to economics. Recently, there has been an effort to find new sources of pectin, such as using the leftovers from the processing of pulp from sugar beet, mango, and sunflower. Pectin substances can affect the human body as follows: prebiotic effect, cholesterol reduction, anti-inflammatory and antimicrobial effect, antitumor effect, biosorbent, transportation of drugs. This article's goal is to discuss pectin application techniques and pectin-containing products. The prospects of further development and use of these biopolymers are also considered.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are licensed under the identical terms.

According to Russian clinical guidelines, there are three main stages of cardiorehabilitation associated with the periodization of the disease. Acute coronary syndrome is one of the most dangerous conditions in the world of modern cardiology, after which patients are at high risk of the appearance and development of chronic pathologies, in particular the development of type 2 diabetes mellitus. According to the latest data, there was a statistically significant increase in the number of new cases of diabetes mellitus after an episode of acute coronary syndrome. Doctors should provide high-quality assistance in the rehabilitation of patients after acute coronary syndrome, especially at the last stage of cardiorehabilitation, which is carried out in outpatient settings.